Immunomodulation

Immunosuppression involves the deliberate reduction of immune system activity to prevent graft rejection in transplant patients, manage autoimmune diseases, or enable successful engraftment in allogeneic stem cell transplantation. It is primarily achieved through pharmacological agents that inhibit lymphocyte proliferation and activation, with combination therapies used to balance efficacy and minimize adverse effects. This strategy is particularly crucial in sensitized individuals or pediatric patients with heightened rejection risk, while also accounting for natural immunosuppressive mechanisms within the immune system itself.